Please assess the completion status of the following clinical trial:

Trial Title: Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Proven first symptomatic deep venous thromboembolic event;~* No known malignancy~* Without: trauma of the legs, surgery within the last 2 months, immobilization within the last 2 months, thrombocytosis (\> 1000 x 109), clinical severe dehydration, deficiency of anti-thrombin III, protein C/S, Factor V Leiden mutation , Prothrombine mutation or circulating lupus anticoagulants, pregnancy or post-partum period~* No indication for malignancy at routine investigations(medical history, physical examination, routine blood tests and chest X-ray)~Exclusion Criteria:~* Proven deep venous thromboembolic event in the medical history~* age under 40 years;

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IVTE, follow-up (Type: None): no malignancy at basal screening, no extensive screening
- IVTE, screening (Type: None): No malignancy at basal screening, screening by means of CT-Chest/abdomen and mammography in women

Based on this trial design, predict the completion outcome and termination type (if applicable).